ivabradine has been researched along with Allodynia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fuseya, S; Ishida, K; Ishida, T; Ito, M; Kawamata, M; Sakamoto, A; Tanaka, S | 1 |
LaĆnez, S; McNaughton, PA; Mehta, I; Tsantoulas, C; Vilar, B; Wong, S | 1 |
Armstrong, G; Bond, S; Lee, MC; McNaughton, P; Menon, D; Scholtes, I; Wheeler, D | 1 |
Bukhanova, N; Chen, Y; Kumar, N; Noh, S; Smith, PA; Stemkowsi, PL | 1 |
2 trial(s) available for ivabradine and Allodynia
Article | Year |
---|---|
A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.
Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic | 2022 |
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.
Topics: Analgesics; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Hyperalgesia; Ivabradine; Neuralgia | 2019 |
2 other study(ies) available for ivabradine and Allodynia
Article | Year |
---|---|
Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy.
Topics: Analgesics; Animals; Benzazepines; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Deletion; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nociception; Pain; Potassium Channels; Proto-Oncogene Proteins c-fos; Sensory Receptor Cells; Skin; Spinal Cord Dorsal Horn; Streptozocin | 2017 |
The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain.
Topics: Analgesics; Animals; Arterial Pressure; Benzazepines; Disease Models, Animal; Female; Heart Rate; Hyperalgesia; Ivabradine; Male; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley | 2014 |